Literature DB >> 16495564

Pneumococcal polysaccharides interact with human dendritic cells.

Ulrike Meltzer1, David Goldblatt.   

Abstract

Dendritic cells (DCs) are critical antigen presentation cells whose influence on murine immune responses to polysaccharide antigens has only recently been elucidated. Little is known about human DC-polysaccharide interactions. We set out to study the interaction between human monocyte-derived DCs and pneumococcal capsular polysaccharides (PPS) in vitro. Immature DCs were generated from peripheral blood monocytes and incubated with fluorescein isothiocyanate-labeled PPS type 9N or 14 for assessment of uptake. DCs were exposed to PPS type 1, 6B, 9N, 14, 19F, or 23F in the absence or presence of Escherichia coli lipopolysaccharide (LPS) for assessment of phenotypic DC maturation and cytokine production. PPS were taken up by immature DCs and proceeded to HLA-DR+ and lysosome-associated membrane protein-1+ late endosomal compartments. Uptake was reduced in the presence of cytochalasin D and wortmannin, suggesting that both cytoskeletal rearrangements and phosphatidylinositol 3-kinase activation may be required for internalization. None of the PPS tested induced DC phenotype changes, maturation, or interleukin-12 (IL-12)/IL-10 production. However, PPS were capable of modulating the response of the DCs to a second signal such as LPS. Exposure of DCs to PPS in the presence of LPS resulted in an altered cytokine balance with significantly increased IL-10 production and reduced IL-12 production compared to LPS alone. This effect was not seen using the control antigen tetanus toxoid. DC-pneumococcus interaction may affect subsequent immune responses to pneumococci, as an altered cytokine balance may have a profound effect on DC-driven T-cell priming.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495564      PMCID: PMC1418647          DOI: 10.1128/IAI.74.3.1890-1895.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Transport of peptide-MHC class II complexes in developing dendritic cells.

Authors:  S J Turley; K Inaba; W S Garrett; M Ebersold; J Unternaehrer; R M Steinman; I Mellman
Journal:  Science       Date:  2000-04-21       Impact factor: 47.728

2.  Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.

Authors:  R Borrow; D Goldblatt; N Andrews; P Richmond; J Southern; E Miller
Journal:  J Infect Dis       Date:  2001-07-10       Impact factor: 5.226

3.  Dendritic cells associated with plasmablast survival.

Authors:  C García De Vinuesa; A Gulbranson-Judge; M Khan; P O'Leary; M Cascalho; M Wabl; G G Klaus; M J Owen; I C MacLennan
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

4.  In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands.

Authors:  Goutam Sen; Abdul Q Khan; Quanyi Chen; Clifford M Snapper
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

5.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells.

Authors:  M Kato; T K Neil; D B Fearnley; A D McLellan; S Vuckovic; D N Hart
Journal:  Int Immunol       Date:  2000-11       Impact factor: 4.823

7.  Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor.

Authors:  J Nigou; C Zelle-Rieser; M Gilleron; M Thurnher; G Puzo
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

8.  The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells.

Authors:  E M Hiltbold; A M Vlad; P Ciborowski; S C Watkins; O J Finn
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

9.  Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms.

Authors:  Jesus Colino; Yi Shen; Clifford M Snapper
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis.

Authors:  Peter McGuirk; Chantelle McCann; Kingston H G Mills
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

View more
  9 in total

1.  Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways.

Authors:  Cynthia Calzas; Guillaume Goyette-Desjardins; Paul Lemire; Fleur Gagnon; Claude Lachance; Marie-Rose Van Calsteren; Mariela Segura
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

Review 2.  Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?

Authors:  Ioanna Papadatou; Vana Spoulou
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

3.  Mouse dendritic cells pulsed with capsular polysaccharide induce resistance to lethal pneumococcal challenge: roles of T cells and B cells.

Authors:  Noam Cohen; Raanan Margalit; Meirav Pevsner-Fischer; Simon Yona; Steffen Jung; Lea Eisenbach; Irun R Cohen
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

4.  Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.

Authors:  Lauren E Yauch; Jennifer S Lam; Stuart M Levitz
Journal:  PLoS Pathog       Date:  2006-11       Impact factor: 6.823

Review 5.  Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review.

Authors:  Cornelius Remschmidt; Thomas Harder; Ole Wichmann; Christian Bogdan; Gerhard Falkenhorst
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

6.  Immune-responsiveness of CD4+ T cells during Streptococcus suis serotype 2 infection.

Authors:  Marie-Pier Lecours; Corinne Letendre; Damian Clarke; Paul Lemire; Tristan Galbas; Marie-Odile Benoit-Biancamano; Jacques Thibodeau; Marcelo Gottschalk; Mariela Segura
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

7.  Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.

Authors:  Cynthia Calzas; Morgan Taillardet; Insaf Salem Fourati; David Roy; Marcelo Gottschalk; Hugo Soudeyns; Thierry Defrance; Mariela Segura
Journal:  Pathogens       Date:  2017-04-20

8.  The Effect of a BSA Conjugate of a Synthetic Hexasaccharide Related to the Fragment of Capsular Polysaccharide of Streptococcus pneumoniae Type 14 on the Activation of Innate and Adaptive Immune Responses.

Authors:  Nelli K Akhmatova; Ekaterina A Kurbatova; Elvin A Akhmatov; Nadezhda B Egorova; Denis Yu Logunov; Marina L Gening; Elena V Sukhova; Dmitry V Yashunsky; Yury E Tsvetkov; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

9.  Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae.

Authors:  Yongqiang Deng; Jing Li; Chunyun Sun; Hang Chi; Dan Luo; Rui Wang; Hongying Qiu; Yanjing Zhang; Mei Wu; Xiao Zhang; Xun Huang; Liangzhi Xie; Chengfeng Qin
Journal:  Adv Mater       Date:  2022-04-21       Impact factor: 32.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.